Antihypertensive medication classes and the risk of dementia over a decade of follow-up-Reference-Cited by-同舟云学术

Antihypertensive medication classes and the risk of dementia over a decade of follow-up

Published:2022-11-18 Issue:2 Volume:41 Page:262-270
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Schroevers Jakob L.,Eggink Esmé,Hoevenaar-Blom Marieke P.,Van Dalen Jan Willem,Van Middelaar Tessa,Van Gool Willem A.,Richard Edo,Moll Van Charante Eric P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference39 articles.

1. Midlife blood pressure and dementia: the Honolulu-Asia aging study;Launer;Neurobiol Aging,2000

2. Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study;Yamada;J Am Geriatr Soc,2003

3. Temporal evolution of cognitive changes in incident hypertension: prospective cohort study across the adult age span;Kohler;Hypertension,2014

4. Blood pressure, cognitive dysfunction, and dementia;Eftekhari;J Am Soc Hypertens,2007

5. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data;Norton;Lancet Neurol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands;The Lancet Regional Health - Europe;2024-07

2. Vascular dementia: From pathobiology to emerging perspectives;Ageing Research Reviews;2024-04

3. Angiotensin Receptor Blockers and Cognition: a Scoping Review;Current Hypertension Reports;2023-09-21